BROAD ARROW ACHIEVES NUMEROUS WORLD RECORD PRICES AT 2025 MONTEREY JET CENTER AUCTION

(NYSE:HGTY), Grosse Pointe, Michigan, Aug. 18, 2025 (GLOBE NEWSWIRE) — Broad Arrow Auctions, a Hagerty (NYSE: HGTY) company, saw no less than eight new record auction prices set at its annual flagship Monterey Jet Center sale, held August 13-14 in conjunction with Motorlux, the sold-out official kick-off to Monterey Car Week. The auction achieved $57.4

BROAD ARROW ACHIEVES NUMEROUS WORLD RECORD PRICES AT 2025 MONTEREY JET CENTER AUCTION

BROAD ARROW ACHIEVES NUMEROUS WORLD RECORD PRICES AT 2025 MONTEREY JET CENTER AUCTION AUCTION LED BY MASERATI MC12 STRADALE AT $5.2 MILLION–THE MOST VALUABLE MODERN MASERATI SOLD AT AUCTION | ADDITIONAL RECORDS SET AS MODERN COLLECTIBLES HIGHLIGHT TWO-DAY SALE | VIEW COMPLETE RESULTS AT BROADARROWAUCTIONS.COM GlobeNewswire August 18, 2025 Grosse Pointe, Michigan, Aug. 18, 2025

RE/MAX HOLDINGS, INC. ANNOUNCES VIC LOMBARDO AS PRESIDENT OF MORTGAGE SERVICES TO LEAD MOTTO MORTGAGE AND WEMLO BRANDS

Industry veteran to spearhead technology and customer-first initiatives that empower Motto Mortgage franchisees and create stronger growth opportunities for REMAX Broker/Owners RE/MAX Holdings, Inc.(NYSE:RMAX), parent company of REMAX®, one of the world's leading franchisors of real estate brokerage services, and Motto® Mortgage, the first and only national mortgage brokerage franchise brand in the U.S., today

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:VOR), CAMBRIDGE, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, between August 4, 2025, and August 18, 2025, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 6,959,013 shares of Vor Bio's

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire August 18, 2025 CAMBRIDGE, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, between August 4, 2025, and August 18, 2025, the Compensation Committee of the Board of Directors

Key Investment Group to Defend Against FTC’s Misapplication of BOTS Act

FTC lawsuit threatens secondary ticket market and consumer choice Key Investment Group (KIG), a leading secondary market ticketing company, announced today that it will vigorously defend itself against a lawsuit filed by the Federal Trade Commission (FTC). The case threatens to dismantle the secondary ticket market for live events, further consolidating power in the hands

Invivyd Announces Continued Neutralizing Activity of PEMGARDA(R) (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)

(NasdaqGM:IVVD), New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA(R) (pemivibart) against XFG Centers for Disease Control data and wastewater surveillance data indicate XFG variant appears to be driving a growing wave of COVID-19 in America VYD2311 in vitro neutralization data demonstrate similarly consistent and highly potent results against XFG Similar new,

Invivyd Announces Continued Neutralizing Activity of PEMGARDA(R) (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)

Invivyd Announces Continued Neutralizing Activity of PEMGARDA(R) (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”) GlobeNewswire August 18, 2025 New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA(R) (pemivibart) against XFG Centers for Disease Control data and wastewater surveillance data indicate XFG variant appears to be driving a growing wave

Scroll to Top